| Accession Number | 0001193125-26-071503 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CMO, Head-Res&Drug | Class A Common Stock | โ | Feb 23, 2026 | Sale | 15,570 | $3.81 | $59,321.70 | 538,437 | Direct | โ | View Details | |
SVP, CMO, Head-Res&Drug | Common Stock | โ | Feb 24, 2026 | Sale | 17,012 | $3.66 | $62,263.92 | 521,425 | Direct | โ | View Details |